(Rac) -JBJ-04-125-02
JBJ-04-125-02 demonstrates efficacy as a monotherapy in EGFR-mutant lung cancer models, both in vitro and in vivo. This small molecule inhibitor is a research tool for studying oncogenic EGFR signaling and evaluating potential therapeutic strategies in preclinical cancer research.
Product Specifications
CAS Number
2140807-05-0
Product Name Alternative
Anti-proliferation, anti-tumor, (Rac) JBJ 04 125 02, (Rac) JBJ0412502, Allosteric, EGFR, EGFR (L858R/T790M), Epidermal growth factor receptor, ErbB-1, Inhibitor, HER1, inhibit, JBJ-04-125-02, T790M-mutant, racemate
Field of Research
Cardiovascular Research, Signal Transduction
Purity
95.85% (May vary between batches)
Solubility
DMSO:55 mg/mL (101.18 mM)
Smiles
Oc1ccc (F) cc1C (N1Cc2ccc (cc2C1=O) -c1ccc (cc1) N1CCNCC1) C (=O) Nc1nccs1
Molecular Formula
C29H26FN5O3S
Molecular Weight
543.61
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV710772 1.0 µg DNA
HAGHL Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Sign In for Pricing
View Details 